Mary-Ellen Taplin

Systemic Therapy in Patiënten met Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 202...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 februari 2026

Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Ph...

Clinical cancer research : an official journal of the American Association for Cancer Research · 4 februari 2026

Systemic Therapy in Patiënten met Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 juli 2025

Intensivering van androgeenblokkade bij hoogrisico prostaatcarcinoom: PRESTO fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 april 2024

Enzalutamide versus enzalutamide plus abiraterone bij mCRPC: PRESIDE fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 juni 2023

Gevorderd prostaatcarcinoom: ESMO 2023 richtlijn update

European journal of cancer (Oxford, England : 1990) · 2023-05

Olaparib met of zonder cediranib bij mCRPC: NCI9012 fase II

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 februari 2023

Niet-gecastreerd gevorderd prostaatcarcinoom: ASCO 2021 richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2021

Radicale prostatectomie met of zonder neoadjuvante chemohormoontherapie: CALGB 90203 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 september 2020

Intensieve neoadjuvante ADT met enzalutamide voor prostatectomie: fase II

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2019

Panobinostat plus bicalutamide bij castratieresistent prostaatcarcinoom: fase I/II

Clinical cancer research : an official journal of the American Association for Cancer Research · 1 januari 2019

Abiraterone alleen of plus enzalutamide bij mCRPC: Alliance A031201 gerandomiseerde studie

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2018

Muscadine druivenschilextract bij biochemisch recidief prostaatcarcinoom: fase II

Clinical cancer research : an official journal of the American Association for Cancer Research · 15 januari 2018

Weefselabirateronspiegels en SLCO-genotype bij neoadjuvant enzalutamide-abiraterone bij prostaatcarcinoom

Clinical cancer research : an official journal of the American Association for Cancer Research · 15 augustus 2017

Neoadjuvant enzalutamide vóór prostatectomie: fase II-studie

Clinical cancer research : an official journal of the American Association for Cancer Research · 1 mei 2017

Gerandomiseerde fase II-studie naar korte androgeendeprivatie met of zonder bevacizumab bij recidief prostaatcarcinoom

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 juni 2016

Trialontwerp en doelstellingen bij castratieresistent prostaatcarcinoom: geactualiseerde PCWG3-aanbevelingen

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 april 2016